A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archophthalmol.2009.234PMID 19752419PMCID PMC2872173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.

  2009cited by this paper
• Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.

  2009cited by this paper
• SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.

  2009cited by this paper
• SCORE Study report 3: study design and baseline characteristics.

  2009cited by this paper
• The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.

  2009cited by this paper
• ISIS-DME: A Prospective, Randomized, Dose-Escalation Intravitreal Steroid Injection Study for Refractory Diabetic Macular Edema

  2008cited by this paper
• Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression.

  2008influential reference
• Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas

  2008cited by this paper
• Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect

  2008influential reference
• Intravitreal Silicone Oil Droplets After Intravitreal Drug Injections

  2008cited by this paper
• The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study.

  2008influential reference
• Role of inflammation in retinal vein occlusion.

  2007influential reference
• Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study.

  2006influential reference
• Long-Term Visual Outcomes of Vitrectomy for Cystoid Macular Edema Due to Nonischemic Central Retinal Vein Occlusion

  2006influential reference
• INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSION: A Short-Term Study

  2006cited by this paper
• Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.

  2006influential reference
• Interventions for central retinal vein occlusion: an evidence-based systematic review.

  2006cited by this paper
• Interventions for branch retinal vein occlusion: an evidence-based systematic review.

  2006cited by this paper
• Silicone oil droplets following intravitreal injection.

  2006cited by this paper
• New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer?

  2005influential reference
• Intravitreal Triamcinolone Acetonide for Macular Edema Associated With Diabetic Retinopathy and Venous Occlusive Disease: It’s Time for Clinical Trials

  2005influential reference
• Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.

  2005cited by this paper
• Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy

  2005influential reference
• INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR DIABETIC MACULAR EDEMA

  2005cited by this paper
• Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.

  2005cited by this paper
• Diffuse intraocular dispersion of triamcinolone particles as a cause of sterile endophthalmitis.

  2004cited by this paper
• Neuroprotection in ophthalmology: a review.

  2004cited by this paper
• Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.

  2004cited by this paper
• Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.

  2004influential reference
• Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.

  2003cited by this paper
• Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion.

  2003influential reference
• A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

  2003influential reference
• Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

  2002influential reference
• Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.

  2002influential reference
• Retinal Thickness in Healthy and Diabetic Subjects Measured Using Optical Coherence Tomography Mapping Software

  2002cited by this paper
• Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C

  2002influential reference
• RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION: A Retrospective Pilot Study of 11 Consecutive Cases

  2001cited by this paper
• The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4.

  2001cited by this paper
• The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4.

  2001cited by this paper
• Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease

  2000cited by this paper
• Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study

  2000influential reference
• Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis

  1999cited by this paper
• Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1

  1999influential reference
• Vascular endothelial growth factor upregulation in human central retinal vein occlusion.

  1998cited by this paper
• Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.

  1997influential reference
• Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.

  1997cited by this paper
• Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.

  1997influential reference
• Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

  1997cited by this paper
• Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.

  1996cited by this paper
• Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.

  1995cited by this paper
• A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin.

  1994influential reference
• Baseline and early natural history report. The Central Vein Occlusion Study.

  1993cited by this paper
• Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure.

  1988cited by this paper
• Inflammation and the mechanism of action of anti‐inflammatory drugs

  1987cited by this paper
• Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

  1983cited by this paper
• On closed testing procedures with special reference to ordered analysis of variance

  1976cited by this paper

• Aqueous humour cytokine profiles in retinal vein occlusion: a comparative study of acute, chronic recurrent, and control eyes.

  2026cites this paper
• The efficacy and safety of intraocular anti-VEGF injections versus anti-VEGF combined with steroids or steroid monotherapy for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis of randomized controlled trials

  2026cites this paper
• Dexamethasone intravitreal implant monotherapy in naive patients with macular edema secondary to retinal vein occlusion: long term follow-up retrospective cohort study.

  2025influential citation
• Safety and efficacy of intravitreal dexamethasone implant on macular edema due to retinal vascular diseases

  2025cites this paper
• Deep learning-based autonomous retinal vein cannulation in ex vivo porcine eyes

  2025cites this paper
• Therapeutic strategies targeting ocular vasculopathies: Current advances and emerging challenges.

  2025cites this paper
• Safety and efficacy of supraciliary dexamethasone implantation for macular oedema: a preliminary comparative study

  2025cites this paper
• Remote Monitoring of Patients with Retinal Vein Occlusions Treated with Anti-VEGF: A Pilot Study

  2025cites this paper
• Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

  2025cites this paper
• Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review

  2025cites this paper
• Effectiveness and cytokine profile of combined anti-vascular endothelial growth factor and corticosteroid therapy for chronic retinal vein occlusion

  2025cites this paper
• Intravitreal therapy—success stories and challenges

  2025cites this paper
• One Intravitreal Dexamethasone Implant versus Single or Multiple Intravitreal Triamcinolone Acetonide Injections for Macular Edema due to Central Retinal Vein Occlusion: Efficacy and Safety

  2025cites this paper
• Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations

  2025cites this paper
• Effect of Suprachoroidal Triamcinolone Acetonide on Intraocular Pressure in Macular Edema: A Retrospective Study

  2025cites this paper
• Risk for Ocular Hypertension With Intravitreal Dexamethasone Implants in Black and White Patients With Diabetic Macular Edema

  2025cites this paper
• Retinal Vein Occlusions Preferred Practice Pattern®.

  2025cites this paper
• Risk factors and incidence of Macular Edema in eyes with retinal Vein Occlusion after uneventful cataract surgery: The MEVO study

  2025cites this paper
• Safety and Efficiency of Anti-VEGF with Dexamethasone Intravitreal Implant for Non-Ischemic Retinal Vein Occlusion: A Prospective, Case-controlled, Cohort Study.

  2024cites this paper
• Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion.

  2024cites this paper
• Analysis of topical conjunctival microbiotic cultures in patients treated with intravitreal injections using antibiotic prophylaxis with 0.3% ofloxacin eye drops

  2024cites this paper
• Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review

  2024cites this paper
• Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection

  2024influential citation
• NONPHARMACOLOGICAL ASPECTS OF INTRAVITREAL DEXAMETHASONE IMPLANT INJECTIONS

  2024influential citation
• Tata Laksana Oklusi Vena Retina Sentral

  2024cites this paper
• Retinal Vein Occlusion–Background Knowledge and Foreground Knowledge Prospects—A Review

  2024cites this paper
• Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study

  2023cites this paper
• Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis

  2023cites this paper
• Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomes

  2023cites this paper
• Acute unilateral visual disturbance.

  2023cites this paper
• Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion.

  2023cites this paper
• Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders

  2023cites this paper
• Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide

  2023cites this paper
• Management of Retinal Vein Occlusions: Review of Evidence-based Treatment

  2023cites this paper
• SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.

  2023cites this paper
• Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis

  2023influential citation
• Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate

  2023cites this paper
• Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases

  2023cites this paper
• Update on Retinal Vein Occlusion

  2023cites this paper
• Macrophage-like Cells Are Increased in Retinal Vein Occlusion and Correlate with More Intravitreal Injections and Worse Visual Acuity Outcomes

  2022cites this paper
• Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data.

  2022cites this paper
• [Retinal vein occlusion : Intravitreal pharmacotherapies and treatment strategies for the management of macular edema].

  2022cites this paper
• A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion

  2022cites this paper
• Effect of a Dexamethasone Implant on Rheological Blood Parameters in Patients Treated for Retinal Vein Thrombosis

  2022cites this paper
• Optical coherence tomography angiography evaluation of retinal and optic disc microvascular morphological characteristics in retinal vein occlusion.

  2022cites this paper
• Month 60 Outcomes after Treatment Initiation with Anti-VEGF Therapy for Macular Edema due to Central or Hemi-Retinal Vein Occlusion.

  2022cites this paper
• Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 1

  2022cites this paper
• TRAKYA BÖLGESİNDE GÖRÜLEN RETİNA VEN KÖK TIKANIKLIKLARINDA KLİNİK SEYİR VE PROGNOZ

  2022cites this paper
• Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology

  2022cites this paper
• Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis

  2022cites this paper
• Long-term real-world outcomes in retinal vein occlusions: How close are we to the trials?

  2022cites this paper
• Treatment of macular diseases: an overview of key randomized clinical trials

  2022cites this paper
• Anatomic Biomarkers in Macular Edema Associated with Retinal Vein Occlusion.

  2022cites this paper
• Epiretinal Membrane Peeling in Eyes with Retinal Vein Occlusion: Visual and Morphologic Outcomes

  2022cites this paper
• EFFICACY OF COMBINED INTRAVITREAL INJECTIONS OF BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE IN PATIENTS WITH NON-RESOLVING MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

  2021cites this paper
• Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

  2021cites this paper
• Türkiye’de retinal ven tıkanıklığı tanısında endikasyon dışı ilaç kullanımı

  2021cites this paper
• [Drug-induced uveitis].

  2021cites this paper
• Photocoagulation for retinal vein occlusion.

  2021cites this paper
• Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

  2021cites this paper
• Retinal vein occlusion: drug targets and therapeutic implications

  2021cites this paper
• The effect of posterior vitreous detachment induced by intravitreal injections on macular edema with retinal vein occlusion

  2021cites this paper
• Background Factors Affecting Visual Acuity at Initial Visit in Eyes with Central Retinal Vein Occlusion: Multicenter Study in Japan

  2021cites this paper
• Effect of single intravitreal triamcinolone acetonide injection on intraocular pressure and retinal nerve fibre layer thickness

  2021cites this paper
• Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema

  2021cites this paper
• The effect of intravitreal dexamethasone implant on central foveal thickness and choroidal thickness in retinal vein occlusion

  2021cites this paper
• PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: A Randomized Double-Masked Controlled Clinical Trial.

  2020cites this paper
• Treatment outcomes of retinal vein occlusion in clinical practice in Nepal

  2020cites this paper
• IMPACT OF RETINAL ISCHEMIA ON FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN PATIENTS WITH RETINAL VEIN OCCLUSION.

  2020cites this paper
• Efficacy and Safety of Ranibizumab in Asian Patients with Branch Retinal Vein Occlusion: Results from the Randomized BLOSSOM Study.

  2020cites this paper
• Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion

  2020cites this paper
• Central Retinal Vein Occlusion

  2020cites this paper
• Retinal vascular occlusions.

  2020cites this paper
• TRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN–INDUSTRY INTERACTIONS

  2020cites this paper
• Visual Acuity in Retinal Vein Occlusion-, Diabetic-, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.

  2020cites this paper
• Quantitative cone contrast threshold testing in patients with differing pathophysiological mechanisms causing retinal diseases

  2020cites this paper
• Cost-Utility of Anti-VEGF Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.

  2020cites this paper
• One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion

  2020cites this paper
• Noninfectious endophthalmitis following intravitreal triamcinolone acetonide: a clinical case and literature review.

  2020cites this paper
• Clinical characteristics of branch retinal vein occlusion with increased retinal haemorrhage during treatment for macular oedema

  2020cites this paper
• Molecular Mechanisms of Retina Pathology and Ways of its Correction

  2020cites this paper
• The efficacy of dexamethasone implants following anti-VEGF failure for macular oedema in retinal vein occlusion

  2020cites this paper
• Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients

  2020cites this paper
• SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes with Central or Hemiretinal Vein Occlusion Managed with Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.

  2020cites this paper
• Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study

  2020cites this paper
• Comparative efficacy of intravitreal pharmacotherapy for macular edema secondary to retinal vein occlusion

  2020cites this paper
• Retinal Venous Occlusive Disease

  2020cites this paper
• Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF

  2020cites this paper
• Cytokines and Pathogenesis of Central Retinal Vein Occlusion

  2020cites this paper
• A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion

  2020cites this paper
• Current Best Clinical Practices—Management of Retinal Vein Occlusion

  2020cites this paper
• Analysis of intravitreal injections at the State Public Servant Hospital of São Paulo

  2020cites this paper
• Use Of Anti-Vegf Drugs In Retinal Vein Occlusions.

  2020cites this paper
• Clinically established biodegradable long acting injectables: An industry perspective.

  2020cites this paper
• Silicone oil droplets in repackaged anti–vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination

  2020cites this paper
• Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up

  2020cites this paper
• Quantitative Assessment of Non Diabetic Macular Edema after Verious Treatment Modalities

  2020cites this paper
• Predictive factors of outcome of selective retina therapy for diabetic macular edema

  2020cites this paper
• ASSESSMENT OF HYPERREFLECTIVE FOCI AFTER BEVACIZUMAB OR DEXAMETHASONE TREATMENT ACCORDING TO DURATION OF MACULAR EDEMA IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION.

  2020cites this paper
• Literature Review

  2020cites this paper